about
Risk Factors and Adverse Outcomes of Severe Hypoglycemia in Type 2 Diabetes MellitusDiabetic Cardiovascular Autonomic Neuropathy Predicts Recurrent Cardiovascular Diseases in Patients with Type 2 Diabetes.Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes.Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea.Response: Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea (Diabetes Metab J 2016;40:482-93).Monotherapy in Patients with Type 2 Diabetes Mellitus.Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017.Effect of resveratrol treatment on graft revascularization after islet transplantation in streptozotocin-induced diabetic mice.Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitusProgression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetesMetformin treatment for patients with diabetes and chronic kidney disease: A Korean Diabetes Association and Korean Society of Nephrology consensus statementSevere hypoglycemia and the risk of cardiovascular disease and mortality in type 2 diabetes: a nationwide population-based cohort studyThe association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort studyEffect of sodium-glucose cotransporter 2 inhibitor, empagliflozin, and α-glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes
P50
Q28072980-93B44CD3-B50D-423D-8D4A-6D76207CC64AQ36163949-DCD228D9-B04E-4443-98C2-994799F130D4Q36179371-C15EB419-F284-44F1-ACFD-3D86E658E1F5Q37056836-E10962CD-E2BB-4696-9C7B-54295E7C52D7Q37516050-970FEFA2-A412-48AF-AC40-E3CE34D3A984Q42319595-36FAD995-33CD-4995-99EC-EC2A82211DA3Q47110030-0B675CB2-C58F-4FCE-A79B-01FBEBDFC16EQ47142499-D974DC7F-BE21-44AE-B1C2-03E95C68647EQ48244709-B49F6F46-3B81-4A28-B286-126C35E78C89Q57290099-3221DCFD-D547-4854-8BF6-4D0E5EE880BBQ58803928-9E2709A7-E7DA-4CD5-952D-A6A60A53B49DQ90075410-A8E39CD1-ABFA-43A7-ADC3-1BEF97BEB31FQ92621328-6EC0A22C-331A-405A-8174-1FD5CD2EE338Q92914480-D02B4EC4-E89D-4522-BFA5-655885AF7A8BQ93357389-B6EAE16E-CBBD-435F-9716-1145DDE63350
P50
description
researcher
@en
wetenschapper
@nl
name
Seung Hyun Ko
@en
Seung Hyun Ko
@nl
type
label
Seung Hyun Ko
@en
Seung Hyun Ko
@nl
prefLabel
Seung Hyun Ko
@en
Seung Hyun Ko
@nl
P31
P496
0000-0003-3703-1479